AKT1 and neoplasm: Together, we demonstrated that the combination of alpelisib + OT is tolerable in a NSG mice xenograft RMS PDXs, significantly decreased PIK3CA/AKT pathway activity and p-NRF2, and ultimately inhibited MDR mechanisms to decreased tumor volume and subsequently prolonged survival.